abbvie glp-1 receptor agonist weight management diabetes treatments Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch Contemporary Management of Obesity: A
Description
Given that these results were coming from a randomised, double-blind clinical trial, the Parkinsons community got rather excited about them ( Click here to read a previous SoPD post about this particular trial)
In another, 6.8% discontinued the medication entirely due to these effects
However, for medications with a narrow therapeutic index , such as digoxin, closer monitoring is necessary
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
Sara Karjoo MD is part of the speaker's bureau for Abbott, Nutricia, Mirum, and Ipsen
Scientists are still researching to understand the connection between Zepbound and vision loss
Lemen, Y
